SCHEMBL26473138

SCHEMBL26473138

CCOc1cc(C)c(OC)cc1-c1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 7/20 0.54
▸ CYP11B2 P19099 7/20 0.54
▸ CYP19A1 P11511 5/20 0.54
▸ CYP3A4 P08684 2/20 0.54
▸ MAPT P10636 3/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ MKNK1 Q9BUB5 2/20 0.49
▸ MKNK2 Q9HBH9 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ ALPL P05186 2/20 0.46
▸ PDE10A Q9Y233 1/20 0.46
▸ S1PR1 P21453 2/20 0.45
▸ PDGFRB P09619 1/20 0.45
▸ PDGFRA P16234 1/20 0.45
▸ CYP17A1 P05093 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26473067 0.95 MAPT (0.51) CYP11B1CYP11B2CYP19A1CYP3A4MAPT
SCHEMBL26473085 0.93 CYP11B1 (0.55) CYP11B1CYP11B2CYP19A1CYP3A4MAPT
SCHEMBL23326169 0.89 MKNK1 (0.56) CYP11B1CYP11B2CYP19A1CYP3A4MAPT
SCHEMBL29775379 0.89 MKNK1 (0.56) CYP11B1CYP11B2CYP19A1CYP3A4MAPT
SCHEMBL26473195 0.88 PDE10A (0.48) CYP11B1CYP11B2CYP19A1CYP3A4MAPT
SCHEMBL29775344 0.85 CYP11B1 (0.54) CYP11B1CYP11B2CYP19A1CYP3A4MAPT
SCHEMBL23326295 0.85 CYP11B1 (0.54) CYP11B1CYP11B2CYP19A1CYP3A4MAPT
SCHEMBL23326124 0.83 MKNK1 (0.51) CYP11B1CYP11B2CYP19A1CYP3A4MAPT
SCHEMBL23326242 0.82 CYP11B1 (0.51) CYP11B1CYP11B2CYP19A1CYP3A4MAPT
SCHEMBL29775399 0.82 CYP11B1 (0.51) CYP11B1CYP11B2CYP19A1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11642336-B2 5-HT2A agonists for use in treatment of depression Lophora ApS (DK) 2023-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11642336-B2 5-HT2A agonists for use in treatment of depression HTR2A, HTR2C, HTR5A CYP11B1 1886/4885CYP11B2 855/4885CYP19A1 894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback